10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
ELEVANCE HEALTH, INC. | |||
Ticker: ELV Fiscal Year: 2016 | |||
Consolidated Statements of Income | |||
Period Ending Dec 31, 2016 10-K (Filed: Feb 22, 2017) | |||
| (In Thousands, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2016 | Dec 31, 2015 | Dec 31, 2014 | |
| Revenues | |||
| Premiums | $ 78,860,100 | 73,385,100 | 68,389,800 |
| Administrative fees | 5,298,800 | 4,976,600 | 4,590,600 |
| Other revenue | 35,100 | 43,100 | 41,300 |
| Total operating revenue | 84,194,000 | 78,404,800 | 73,021,700 |
| Net investment income | 779,500 | 677,600 | 724,400 |
| Net realized gains on financial instruments | 4,900 | 157,500 | 177,000 |
| Other than temporary impairment losses on investments: | |||
| Total other-than-temporary impairment losses on investments | (147,100) | (99,900) | (56,200) |
| Portion of other-than-temporary impairment losses recognized in other comprehensive income | 31,700 | 16,500 | 7,200 |
| Other-than-temporary impairment losses recognized in income | (115,400) | (83,400) | (49,000) |
| Total revenues | 84,863,000 | 79,156,500 | 73,874,100 |
| Expenses | |||
| Benefit expense | 66,834,400 | 61,116,900 | 56,854,900 |
| Selling, general and administrative expense: | |||
| Selling expense | 1,391,500 | 1,441,100 | 1,490,100 |
| General and administrative expense | 11,166,400 | 11,093,700 | 10,258,300 |
| Total selling, general and administrative expense | 12,557,900 | 12,534,800 | 11,748,400 |
| Interest expense | 723,000 | 653,000 | 600,700 |
| Amortization of other intangible assets | 192,300 | 230,100 | 220,900 |
| (Gain) loss on extinguishment of debt | 0 | (9,300) | 81,100 |
| Total expenses | 80,307,600 | 74,525,500 | 69,506,000 |
| Income from continuing operations before income tax expense | 4,555,400 | 4,631,000 | 4,368,100 |
| Income tax expense | 2,085,600 | 2,071,000 | 1,808,000 |
| Income from continuing operations | 2,469,800 | 2,560,000 | 2,560,100 |
| Income from discontinued operations, net of tax | 0 | 0 | 9,600 |
| Net income | 2,469,800 | 2,560,000 | 2,569,700 |
| Basic net income per share: | |||
| Basic - continuing operations (in dollars per share) | 9.39 | 9.73 | 9.28 |
| Basic - discontinued operations (in dollars per share) | 0.00 | 0.00 | 0.03 |
| Basic net income per share | 9.39 | 9.73 | 9.31 |
| Diluted net income per share: | |||
| Diluted - continuing operations (in dollars per share) | 9.21 | 9.38 | 8.96 |
| Diluted - discontinued operations (in dollars per share) | 0.00 | 0.00 | 0.03 |
| Diluted net income per share | 9.21 | 9.38 | 8.99 |
| Dividends per share | 2.60 | 2.50 | 1.75 |
| External Links | |
| ELEVANCE HEALTH, INC. (ELV) Fiscal Year 2016 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |